AAN 2026 18 - 22 April 2026

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Neurology
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)